Literature DB >> 10710337

Alterations in relaxation to lactate and H(2)O(2) in human placental vessels from gestational diabetic pregnancies.

R Figueroa1, E Martinez, R P Fayngersh, N Tejani, K M Mohazzab-H, M S Wolin.   

Abstract

We determined whether alterations in the mechanism of relaxation to H(2)O(2) potentially contribute to the enhanced prostaglandin-mediated contractile response to H(2)O(2) and posthypoxic reoxygenation seen in human placental vessels of pregnancies with gestational diabetes mellitus (GDM). Isolated placental arteries and veins from GDM and uncomplicated full-term pregnancies were precontracted with prostaglandin F(2alpha) (PO(2) 35-38 Torr) and then exposed to lactate (1-10 mM), arachidonic acid (0.01-10 microM), nitroglycerin (1 nM-1 microM), forskolin (0.01-10 microM), or H(2)O(2) (1 microM-1 mM + 10 microM indomethacin). The rates of tissue H(2)O(2) metabolism by catalase and nitrite production were measured. The relaxation to lactate was reduced in GDM placental arteries and veins by 54-85 and 66-80%, and the relaxation to H(2)O(2) was inhibited by 80-94% in GDM placental veins compared with vessels from uncomplicated full-term pregnancies. H(2)O(2) caused only minimal relaxation of placental arteries. Responses to other relaxing agents were not altered in the GDM placental vessels. Diabetic vessels showed rates of nitrite production that were increased by 113-195% and rates of H(2)O(2) metabolism by catalase that were decreased by 44-61%. The loss of relaxation to H(2)O(2) and lactate (mediated via H(2)O(2)), perhaps as a result of the inhibition of catalase by nitric oxide, may explain the previously reported enhancement of prostaglandin-mediated contractile responses to H(2)O(2) and posthypoxic reoxygenation seen in GDM placental vessels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10710337     DOI: 10.1152/ajpheart.2000.278.3.H706

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

Review 1.  The placenta and gestational diabetes mellitus.

Authors:  M Gauster; G Desoye; M Tötsch; U Hiden
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

Review 2.  The feto-placental endothelium in pregnancy pathologies.

Authors:  Christian Wadsack; Gernot Desoye; Ursula Hiden
Journal:  Wien Med Wochenschr       Date:  2012-05

3.  Role of Altered Venous Blood Lactate and HbA1c in Women with Gestational Diabetes Mellitus.

Authors:  C S Nagalakshmi; N U Santhosh; N Krishnamurthy; Chethana Chethan; M K Shilpashree
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 4.  Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.

Authors:  Andrea Leiva; Fabián Pardo; Marco A Ramírez; Marcelo Farías; Paola Casanello; Luis Sobrevia
Journal:  Exp Diabetes Res       Date:  2011-11-24

Review 5.  Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming.

Authors:  Li-Tung Huang; Chih-Sung Hsieh; Kow-Aung Chang; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2012-11-09       Impact factor: 5.923

Review 6.  Is a low level of free thyroxine in the maternal circulation associated with altered endothelial function in gestational diabetes?

Authors:  Enrique Guzmán-Gutiérrez; Carlos Veas; Andrea Leiva; Carlos Escudero; Luis Sobrevia
Journal:  Front Pharmacol       Date:  2014-06-06       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.